Clare Dyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Latest Publications
David Southall: anatomy of a wrecked career
After 14 years in the rifle sights of the General Medical Council, the paediatrician David Southall has now had the final case against him dropped. Clare Dyer unpicks how he was failed by the regulatory system and what steps have been taken to make sure no other doctor has to go through such an ordeal David Southall, a professor of paediatrics and child protection specialist with a world reputation, was hauled before the UK medical regulator not once but three times, accused of serious professional misconduct. The cases dragged on for years, bouncing back and forth between the courts and the regulator. Hearings ran out of time, were adjourned, and then resumed months later. In all, Southall spent 14 unrelenting years in the rifle sights of the General Medical Council before the final case against him was dropped. Serious professional misconduct has been defined as conduct “which would be regarded as deplorable by fellow practitioners.” Yet Southall has had the support of the Royal College of Paediatrics and Child Health and of colleagues on both sides of the Atlantic. In the UK, paediatricians who see what happened to one of the leaders of their profession are loath to put themselves in the firing line and the numbers willing to do child protection work have dropped. “There is something grossly wrong with the medical and legal system which allowed this to happen,” wrote Jerold F Lucey, editor of Pediatrics , the journal of the American Academy of Pediatrics, of Southall’s case and that of Roy Meadow, another professor of paediatrics struck off by the GMC and later reinstated by the court.1 Southall’s problems date back to the mid-1980s when, as a specialist in babies’ breathing problems at the Royal Brompton in London, he couldn’t fathom why some babies would stop …
David Southall: anatomy of a wrecked career
After 14 years in the rifle sights of the General Medical Council, the paediatrician David Southall has now had the final case against him dropped. Clare Dyer unpicks how he was failed by the regulatory system and what steps have been taken to make sure no other doctor has to go through such an ordeal David Southall, a professor of paediatrics and child protection specialist with a world reputation, was hauled before the UK medical regulator not once but three times, accused of serious professional misconduct. The cases dragged on for years, bouncing back and forth between the courts and the regulator. Hearings ran out of time, were adjourned, and then resumed months later. In all, Southall spent 14 unrelenting years in the rifle sights of the General Medical Council before the final case against him was dropped. Serious professional misconduct has been defined as conduct “which would be regarded as deplorable by fellow practitioners.” Yet Southall has had the support of the Royal College of Paediatrics and Child Health and of colleagues on both sides of the Atlantic. In the UK, paediatricians who see what happened to one of the leaders of their profession are loath to put themselves in the firing line and the numbers willing to do child protection work have dropped. “There is something grossly wrong with the medical and legal system which allowed this to happen,” wrote Jerold F Lucey, editor of Pediatrics , the journal of the American Academy of Pediatrics, of Southall’s case and that of Roy Meadow, another professor of paediatrics struck off by the GMC and later reinstated by the court.1 Southall’s problems date back to the mid-1980s when, as a specialist in babies’ breathing problems at the Royal Brompton in London, he couldn’t fathom why some babies would stop …
Ensuring quality in primary care
Monitoring of UK general practitioners has been called “grossly inadequate,” but is it about to improve? Clare Dyer reports
Ensuring quality in primary care
Monitoring of UK general practitioners has been called “grossly inadequate,” but is it about to improve? Clare Dyer reports
Great Ormond Street and Baby P: was there a cover up?
Four years after the death of “Baby P,” arguments are still continuing about the response of the UK’s leading children’s hospital. Clare Dyer reports Baby Peter Connelly had bruises on his face and back and a two month old lesion on his head when he was seen by Sabah Al-Zayyat, a locum consultant paediatrician, at the child development centre at St Ann’s hospital in Tottenham, north London, on 1 August 2007. The bruises were typical of abuse, according to the two leading paediatricians who later reviewed Dr Al-Zayyat’s work at St Ann’s, and should have raised suspicion—particularly in a toddler who, as the notes showed, was on the child protection register. It was the last chance to save his life but it was missed. He was sent home, and a letter went to Great Ormond Street Hospital referring him for investigation for possible metabolic disease. Two days later, aged just 17 months, he was dead. A postmortem examination found eight fractured ribs; a broken back; an area of bleeding around the spine at neck level; numerous bruises, cuts, and abrasions, including a large gouge in his head; a tear in his frenulum that was partially healed; and missing nails. One ear lobe had been pulled away from his head, and a tooth was found in his colon. In November 2008 his mother, Tracey Connelly, her boyfriend, and his brother were convicted of causing or allowing his death, and a media storm erupted. The case of Baby P—his full name was not released at first—became a cause célèbre. The picture of the blond, blue eyed toddler in his bright blue pullover who was so let down by health professionals and social services sparked public outrage. Government ministers looked for someone to blame. Attention focused mainly on the social workers rather than …
Great Ormond Street and Baby P: was there a cover up?
Four years after the death of “Baby P,” arguments are still continuing about the response of the UK’s leading children’s hospital. Clare Dyer reports Baby Peter Connelly had bruises on his face and back and a two month old lesion on his head when he was seen by Sabah Al-Zayyat, a locum consultant paediatrician, at the child development centre at St Ann’s hospital in Tottenham, north London, on 1 August 2007. The bruises were typical of abuse, according to the two leading paediatricians who later reviewed Dr Al-Zayyat’s work at St Ann’s, and should have raised suspicion—particularly in a toddler who, as the notes showed, was on the child protection register. It was the last chance to save his life but it was missed. He was sent home, and a letter went to Great Ormond Street Hospital referring him for investigation for possible metabolic disease. Two days later, aged just 17 months, he was dead. A postmortem examination found eight fractured ribs; a broken back; an area of bleeding around the spine at neck level; numerous bruises, cuts, and abrasions, including a large gouge in his head; a tear in his frenulum that was partially healed; and missing nails. One ear lobe had been pulled away from his head, and a tooth was found in his colon. In November 2008 his mother, Tracey Connelly, her boyfriend, and his brother were convicted of causing or allowing his death, and a media storm erupted. The case of Baby P—his full name was not released at first—became a cause célèbre. The picture of the blond, blue eyed toddler in his bright blue pullover who was so let down by health professionals and social services sparked public outrage. Government ministers looked for someone to blame. Attention focused mainly on the social workers rather than …
The fraud squad
The only UK body dedicated to promoting research integrity had its funding withdrawn last year. So what is the future for policing research fraud? Clare Dyer reports Eric Poehlman holds a unique place in the annals of medical research. Once a highly regarded US researcher on obesity, metabolism, and ageing, he published hundreds of papers and garnered millions of dollars in grants over his 20 year career. In 2006 he became the first biomedical scientist in the US to go to jail for falsifying research data.1 Last year another US serial research fraudster, anaesthesiologist Scott Reuben, was jailed for conducting a series of fraudulent clinical trials of multimodal analgesia over six years.2 Prosecutors in Germany launched a criminal investigation this year after the editors of 16 medical journals retracted 88 articles by professor of anaesthetics Joachim Boldt because he failed to obtain ethical approval. He was stripped of his professorship, and the hospital where he was chief anaesthetist set up an investigating commission to review his work for data fabrication, falsification, or misrepresentation.3 4 In the United Kingdom, the Andrew Wakefield saga has highlighted the inadequacies in the country’s system for tackling research misconduct. Dr Wakefield, a reader in experimental gastroenterology at London’s Royal Free Hospital School of Medicine, sparked a worldwide scare by suggesting a link between autism and the MMR vaccine. He was struck off the medical register in 2010, and only then did the Lancet , which published the research in 1998, retract the article. Although he was ousted from his job in 2001 for refusing to replicate his controversial study, the medical school did only a cursory investigation in 2004 when it was made aware of substantial concerns about his work, and it took a journalist, Brian Deer, to provide clear evidence that …
The fraud squad
The only UK body dedicated to promoting research integrity had its funding withdrawn last year. So what is the future for policing research fraud? Clare Dyer reports Eric Poehlman holds a unique place in the annals of medical research. Once a highly regarded US researcher on obesity, metabolism, and ageing, he published hundreds of papers and garnered millions of dollars in grants over his 20 year career. In 2006 he became the first biomedical scientist in the US to go to jail for falsifying research data.1 Last year another US serial research fraudster, anaesthesiologist Scott Reuben, was jailed for conducting a series of fraudulent clinical trials of multimodal analgesia over six years.2 Prosecutors in Germany launched a criminal investigation this year after the editors of 16 medical journals retracted 88 articles by professor of anaesthetics Joachim Boldt because he failed to obtain ethical approval. He was stripped of his professorship, and the hospital where he was chief anaesthetist set up an investigating commission to review his work for data fabrication, falsification, or misrepresentation.3 4 In the United Kingdom, the Andrew Wakefield saga has highlighted the inadequacies in the country’s system for tackling research misconduct. Dr Wakefield, a reader in experimental gastroenterology at London’s Royal Free Hospital School of Medicine, sparked a worldwide scare by suggesting a link between autism and the MMR vaccine. He was struck off the medical register in 2010, and only then did the Lancet , which published the research in 1998, retract the article. Although he was ousted from his job in 2001 for refusing to replicate his controversial study, the medical school did only a cursory investigation in 2004 when it was made aware of substantial concerns about his work, and it took a journalist, Brian Deer, to provide clear evidence that …
New life for the HFEA?
The government has announced the disbanding of the Human Fertilisation and Embryology Authority, but as Clare Dyer reports, it is not going to go quietly “It’s a very Alice in Wonderland situation,” muses Lisa Jardine. “I feel like the Cheshire cat. I’m smiling a Cheshire cat smile.” The Cheshire cat’s grin, of course, was all that was left after the rest of him disappeared. “Precisely,” she laughs. The organisation she chairs, the Human Fertilisation and Embryology Authority (HFEA), could go up in smoke in the UK government’s bonfire of the quangos, the rationalisation exercise that will see some so called arm’s length bodies abolished and the functions of others taken into government departments or spread among other, larger organisations. The Department of Health is proposing to hand over the authority’s role in regulating fertility clinics to the Care Quality Commission, the general healthcare regulator, and to relocate its other main function, licensing embryo research, within a proposed new agency that will streamline the process of approval for medical research. Yet Jardine, professor of renaissance studies at Queen Mary, University of London, has just been reappointed as the HFEA’s chair for a new three year term. The authority, established in 1991 by the Human Fertilisation and Embryology Act, celebrated its 20th anniversary this month. The birth of the first test tube baby, Louise Brown, in 1978, and the speed at which the technologies of in vitro fertilisation and embryology were developing prompted the government to establish a committee under the philosopher Mary Warnock, now Baroness Warnock, to look at regulation. The 1984 Warnock report concluded that the special status of the human embryo should be enshrined in law but that in vitro fertilisation and research on embryos should be permissible, with appropriate safeguards, and the HFEA was born. The act stipulates …
New life for the HFEA?
The government has announced the disbanding of the Human Fertilisation and Embryology Authority, but as Clare Dyer reports, it is not going to go quietly “It’s a very Alice in Wonderland situation,” muses Lisa Jardine. “I feel like the Cheshire cat. I’m smiling a Cheshire cat smile.” The Cheshire cat’s grin, of course, was all that was left after the rest of him disappeared. “Precisely,” she laughs. The organisation she chairs, the Human Fertilisation and Embryology Authority (HFEA), could go up in smoke in the UK government’s bonfire of the quangos, the rationalisation exercise that will see some so called arm’s length bodies abolished and the functions of others taken into government departments or spread among other, larger organisations. The Department of Health is proposing to hand over the authority’s role in regulating fertility clinics to the Care Quality Commission, the general healthcare regulator, and to relocate its other main function, licensing embryo research, within a proposed new agency that will streamline the process of approval for medical research. Yet Jardine, professor of renaissance studies at Queen Mary, University of London, has just been reappointed as the HFEA’s chair for a new three year term. The authority, established in 1991 by the Human Fertilisation and Embryology Act, celebrated its 20th anniversary this month. The birth of the first test tube baby, Louise Brown, in 1978, and the speed at which the technologies of in vitro fertilisation and embryology were developing prompted the government to establish a committee under the philosopher Mary Warnock, now Baroness Warnock, to look at regulation. The 1984 Warnock report concluded that the special status of the human embryo should be enshrined in law but that in vitro fertilisation and research on embryos should be permissible, with appropriate safeguards, and the HFEA was born. The act stipulates …
The Bribery Act: what it means for you
The new UK Bribery Act makes recipients of bribes liable for prosecution as well as those offering inducements. Clare Dyer examines the implications for doctors Lapdancing club outings, centre court tickets at Wimbledon, greyhound racing—these are all treats enjoyed by doctors a few years ago courtesy of one of the UK’s largest drug companies. The company, Abbott Laboratories, was censured by its industry body, the Association of the British Pharmaceutical Industry (ABPI).1 But from April 2011, any company providing such activities could be prosecuted under the new Bribery Act and end up with a criminal conviction. And so could the doctors who took advantage of the hospitality on offer. The act, which comes into force next April, overhauls the UK’s archaic corruption laws, replacing them with one of the strictest pieces of anticorruption legislation in the world. It is mainly aimed at curbing corporate corruption and creates a new corporate offence of failing to prevent bribery. Not only is it an offence under the act to offer someone a financial or other advantage with the intention to induce that person to perform an action improperly, but it is also an offence to request, agree to receive, …
The Bribery Act: what it means for you
The new UK Bribery Act makes recipients of bribes liable for prosecution as well as those offering inducements. Clare Dyer examines the implications for doctors Lapdancing club outings, centre court tickets at Wimbledon, greyhound racing—these are all treats enjoyed by doctors a few years ago courtesy of one of the UK’s largest drug companies. The company, Abbott Laboratories, was censured by its industry body, the Association of the British Pharmaceutical Industry (ABPI).1 But from April 2011, any company providing such activities could be prosecuted under the new Bribery Act and end up with a criminal conviction. And so could the doctors who took advantage of the hospitality on offer. The act, which comes into force next April, overhauls the UK’s archaic corruption laws, replacing them with one of the strictest pieces of anticorruption legislation in the world. It is mainly aimed at curbing corporate corruption and creates a new corporate offence of failing to prevent bribery. Not only is it an offence under the act to offer someone a financial or other advantage with the intention to induce that person to perform an action improperly, but it is also an offence to request, agree to receive, …
Have we heeded the lessons from Shipman?
The £21m Shipman inquiry recommended fundamental changes to the system that allowed a family doctor to kill undetected for more than 20 years. Ten years on, Clare Dyer investigates what progress has been made Harold “Fred” Shipman was a popular general practitioner (GP) who practised for more than 20 years in Hyde, Greater Manchester. To his patients, there seemed nothing to mark him out from other family doctors in the town. People trust doctors and they trusted him. It took more than two decades to unmask him as the United Kingdom’s most prolific serial killer. In January 2000 he was convicted of murdering 15 of his patients. A four year inquiry chaired by the appeal court judge Dame Janet Smith concluded that the death toll was probably more than 200 between 1971 and 1998. Mostly elderly women but nowhere near death, they were killed in their homes or in his surgery with a large shot of diamorphine. “None of your victims,” Mr Justice Forbes told him when he sentenced him to life imprisonment, “realised that yours was not a healing touch. None of them knew that in truth you had brought her death, death which was disguised as the caring attention of a good doctor.” Like his patients, the system trusted Dr Shipman. He signed the death certificates himself so there was no need to refer the case to the coroner. Fellow GPs to whom he gave a plausible account of the death countersigned the cremation certificates without making their own inquiries. The medical referee who was supposed to scrutinise the forms simply checked that they were filled in properly. The coroner was finally alerted by another GP after an undertaker commented that Dr Shipman’s death rates seemed abnormally high, but a botched and unnecessarily protracted police investigation allowed three …
Have we heeded the lessons from Shipman?
The £21m Shipman inquiry recommended fundamental changes to the system that allowed a family doctor to kill undetected for more than 20 years. Ten years on, Clare Dyer investigates what progress has been made Harold “Fred” Shipman was a popular general practitioner (GP) who practised for more than 20 years in Hyde, Greater Manchester. To his patients, there seemed nothing to mark him out from other family doctors in the town. People trust doctors and they trusted him. It took more than two decades to unmask him as the United Kingdom’s most prolific serial killer. In January 2000 he was convicted of murdering 15 of his patients. A four year inquiry chaired by the appeal court judge Dame Janet Smith concluded that the death toll was probably more than 200 between 1971 and 1998. Mostly elderly women but nowhere near death, they were killed in their homes or in his surgery with a large shot of diamorphine. “None of your victims,” Mr Justice Forbes told him when he sentenced him to life imprisonment, “realised that yours was not a healing touch. None of them knew that in truth you had brought her death, death which was disguised as the caring attention of a good doctor.” Like his patients, the system trusted Dr Shipman. He signed the death certificates himself so there was no need to refer the case to the coroner. Fellow GPs to whom he gave a plausible account of the death countersigned the cremation certificates without making their own inquiries. The medical referee who was supposed to scrutinise the forms simply checked that they were filled in properly. The coroner was finally alerted by another GP after an undertaker commented that Dr Shipman’s death rates seemed abnormally high, but a botched and unnecessarily protracted police investigation allowed three …
Expert witnesses above the parapet
Clare Dyer reports on the problems facing doctors acting as witnesses in child protection cases and attempts to overcome them “My feeling was ‘why take the risk of losing my livelihood?’” This is how Terence Stephenson, president of the Royal College of Paediatrics and Child Health, explained why he decided five years ago to turn down requests to be an expert witness in cases where parents are suspected of making up or causing their child’s illness. He made the disclosure in a statement for the judges hearing the appeal of fellow paediatrician David Southall, who was appealing against being struck off by the General Medical Council for accusing a mother of murdering her son. Professor Stephenson told the court that in the 14 years before his decision he had given advice in 30 such cases. “What changed? In 2005, I was asked by the Medical Defence Union to assist in the preparation of the defence of Roy Meadow. In the same year I was reported for the second time to the GMC regarding a case of fabricated or induced illness.” The GMC ordered Roy Meadow, a former president of the royal college and a pioneer in the recognition of fabricated or induced illness, to be struck off for straying outside his expertise and giving misleading statistical evidence in the case of solicitor Sally Clark. She was jailed for murdering two of her babies but later freed on appeal. Although the High Court subsequently allowed Professor Meadow to stay on the medical register, his reputation among the general public has never recovered. In the years before the GMC took action against them, Meadow and Southall, the leading experts on fabricated or induced illness—then known as Munchausen syndrome by proxy—were targeted in a hate campaign mounted on behalf of parents who claimed …
Expert witnesses above the parapet
Clare Dyer reports on the problems facing doctors acting as witnesses in child protection cases and attempts to overcome them “My feeling was ‘why take the risk of losing my livelihood?’” This is how Terence Stephenson, president of the Royal College of Paediatrics and Child Health, explained why he decided five years ago to turn down requests to be an expert witness in cases where parents are suspected of making up or causing their child’s illness. He made the disclosure in a statement for the judges hearing the appeal of fellow paediatrician David Southall, who was appealing against being struck off by the General Medical Council for accusing a mother of murdering her son. Professor Stephenson told the court that in the 14 years before his decision he had given advice in 30 such cases. “What changed? In 2005, I was asked by the Medical Defence Union to assist in the preparation of the defence of Roy Meadow. In the same year I was reported for the second time to the GMC regarding a case of fabricated or induced illness.” The GMC ordered Roy Meadow, a former president of the royal college and a pioneer in the recognition of fabricated or induced illness, to be struck off for straying outside his expertise and giving misleading statistical evidence in the case of solicitor Sally Clark. She was jailed for murdering two of her babies but later freed on appeal. Although the High Court subsequently allowed Professor Meadow to stay on the medical register, his reputation among the general public has never recovered. In the years before the GMC took action against them, Meadow and Southall, the leading experts on fabricated or induced illness—then known as Munchausen syndrome by proxy—were targeted in a hate campaign mounted on behalf of parents who claimed …
Assisted suicide: the fight goes on
Calls for those who accompany people abroad for assisted suicide to be immune from prosecution were defeated in the House of Lords this month. Clare Dyer talks to Lord Falconer, who proposed the change in the law
Assisted suicide: the fight goes on
Calls for those who accompany people abroad for assisted suicide to be immune from prosecution were defeated in the House of Lords this month. Clare Dyer talks to Lord Falconer, who proposed the change in the law
Doctors in court
Will the General Medical Council’s new guidelines help allay paediatricians’ fears about acting as expert witnesses? Clare Dyer reports
Doctors in court
Will the General Medical Council’s new guidelines help allay paediatricians’ fears about acting as expert witnesses? Clare Dyer reports